Meridian™
Universe

TCRX · CIK 0001783328 · FY2025 live · 2025-12-31

TScan Therapeutics, Inc.

DistressSEC 10-KClassic ZHealthcare37th percentile in Healthcare · 736 names

View as

Model

Classic Z

FY2025

−3.58

Zone

Distress

Prior

—

Market DD

—

1y PD

—

−3.58

Z″ −5.99

−21.83.08+

Score −3.58 · distress below 1.80, grey to 2.99, safe at 3.00 and above.

Classic Z factor contributions

  • X1 Working capital / assets

    Short-term liquidity versus the size of the balance sheet.

    0.61
    1.2 × = 0.73

  • X2 Retained earnings / assets

    Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.

    −2.21
    1.4 × = −3.09

  • X3 EBIT / assets

    Operating return on assets. Highest weight in the original model.

    −0.59
    3.3 × = −1.96

  • X4 Book equity / liabilities

    Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.

    1.17
    0.6 × = 0.70

  • X5 Sales / assets

    Asset turnover — how much revenue the asset base supports.

    0.05
    1 × = 0.05

Five-year path

Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings.

Meridian Rank

22.36

0–100 · Classic Z family

  • Book standing

    21

  • Year change

    —

  • Market PD

    —

  • O-score

    26

Events on this name

Same published rows as Today.

No published events on this print.

Overview

rule-v1

TScan Therapeutics, Inc. is on classic Z at −3.58 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print; EBIT / assets is the runner-up. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers. Buybacks can send retained earnings negative at otherwise healthy issuers. X4 is book equity.

Book screen Distress; market PD —. Market PD has not been priced on this name.

Market DD · naive Merton

No market tape yet.

Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.

Sector peers

Closest Classic Z scores · 37th percentile in Healthcare.

KPI widgets

Current assets

$157M

Total assets

$229M

Current liabilities

$19M

Total liabilities

$106M

Working capital

$139M

Retained earnings

−$505M

EBIT

−$136M

Total sales

$10M

Book equity

$123M

Accession 0001193125-26-089884. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as is a display overlay. X4 is book equity. Pulled 13 Sept 2026.